Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Oct 2021 for Strongbridge Biopharma plc. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Scott L. Wilhoit: trading record in brief
All filings by Scott L. Wilhoit on record concern Strongbridge Biopharma plc, in the capacity of senior executive. The record holds 2 filings, for trades running from 1 October 2021 to 5 October 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 6 October 2021 came the latest disclosure, a transaction in Strongbridge Biopharma plc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Scott L. Wilhoit
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
109,510 sharesOrdinary SharesSEC:0001179110-21-009285:0
27,515 shares@ US$2.06100.0% of flowOrdinary SharesSEC:0001179110-21-009231:0
2 of 2 declarations
